Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts
| Credit Types: | CME |
| Credit Amount: | 21 Credits |
| Release Date: | 2010-May-28 |
| Expiration Date: | 2012-May-27 |
| Estimated Time for Completion: | 60 minutes |
| Registration Required: | No |
| Cost: | Free |
In this activity, an expert in venous thromboembolism prophylaxis discusses strategies for prevention in surgical and medical patients.
Upon completion of this activity, participants should be better able to:
This activity has been designed to meet the educational needs of hospitalists, emergency medicine physicians, and other clinicians involved in VTE prophylaxis.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: May 28, 2010 - May 27, 2012
Time to Complete PeerView inPractice: 60 minutes
In accordance with ACCME requirements, the American Heart Association, has a conflict of interest policy that requires all planning committee members and faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Samuel Z. Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director of the Venous Thromboembolism Research Group
Senior Staff Cardiologist, Cardiovascular Medicine Division
Brigham and Women’s Hospital
Boston, Massachusetts
Samuel Z. Goldhaber, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Medscape; and sanofi-aventis.
Grant/Research Support from Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; and sanofi-aventis.
Nereida A. Crawford, MPH
Science and Medicine Advisor
American Heart Association
Dallas, Texas
Nereida A. Crawford, MPH, currently has no financial interests/relationships or affiliations in relation to this activity.
Dwight E. Randle, PhD
Science and Medicine Advisor
American Heart Association
Dallas, Texas
Dwight E. Randle, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer Research Institute.
Advisory Board for Bayer Research Institute.
Annette Wiggins
PVI, PeerView Institute for Medical Education, Inc.
Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Heart Association and PVI, PeerView Institute for Medical Education. The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Case-Based CME
The American Heart Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Performance Improvement CME
The American Heart Association designates this educational activity for a maximum of 21 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the American Heart Association and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from 
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
Which stage of Performance Improvement CME allows you to evaluate your own practice against a specific measure?
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.